Company Profile
Brodie Generational Capital Partners is a family-owned investment firm that deploys its own capital with a long-term, generational approach. Unlike traditional private equity firms, the company focuses on sustainable growth over decades rather than short-term gains. They partner with public, private, and family-owned businesses, prioritizing legacy and continuity while retaining existing leadership. The firm's investment strategy centers on established, high-performing businesses where their expertise and strategic vision can foster meaningful growth.
The firm was founded in 2022, stemming from the Brodie family's significant capital generated from the sale of their former company, Purolite, a specialty resin and separation technologies business, to Ecolab in 2021 for approximately $3.7 billion. A personal connection to cancer survival within the Brodie family also fuels their passion for investing in cancer research and related healthcare advancements.
Brodie Generational Capital Partners has made notable investments in companies like Zahav Bioscience, a portfolio company pioneering nanoparticle delivery for enhanced cancer therapies, which was formed from the acquisition of CytImmune Sciences in 2023. In late 2025, the firm also acquired Sur-Seal, a leading advanced materials converting and engineered solutions provider, which serves various end markets including industrial, HVAC, lighting, medical, aerospace, automotive, energy storage, and data centers.
The leadership team at Brodie Generational Capital Partners brings extensive experience in business growth, strategic investments, and global operations, with deep roots in manufacturing, life sciences, private equity, and corporate finance. Key team members include Steve Brodie (CEO), Jacob Brodie (President and COO), Albert Luk (Director of Private Investments), and Holly Bretzius (CFO), among others. Their collective expertise is leveraged to identify and support exceptional businesses aligned with their long-term investment philosophy.
News & Signals (0)
No linked news activity found for this company.